Clearance of human brain natriuretic peptide in rabbits; effect of the kidney, the natriuretic peptide clearance receptor, and peptidase activity

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 976-980

  Almirez, Ramona ^a   Protter, Andrew A ^a,b  

^a SCIOS INC   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; ENZYME INHIBITOR; HORMONE RECEPTOR; NATRIURETIC PEPTIDE CLEARANCE RECEPTOR; PEPTIDASE; PHOSPHORAMIDON; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; GLYCOPEPTIDES; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; LIGATION; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; RABBITS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RENAL CIRCULATION;

EID: 0032902882     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Abraham WT, Lowes BD, Ferguson DA, Odom J, Kim JK, Robertson AD, Bristow MR and Schrier RW (1998) Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 4:37-44.
2. Almeida FA, Suzuki M, Scarborough RM, Lewicki JA and Maack T (1989) Clearance function of type C receptors of atrial natriuretic factor in rats. Am J Physiol 256:R469-R475.
3. Bennett BD, Bennett GL, Vitangcol RV, Jewett JR, Burnier J, Henzel W and Lowe DG (1991) Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera. J Biol Chem 266:23060-23067.
4. Charles CJ, Espiner EA, Nicholls MG, Richards AM, Yandle TG, Protter AA and Kosoglou T (1996) Clearance receptors and endopeptidase 24.11: Equal role in natriuretic peptide metabolism in conscious sheep. Am J Physiol 271:R373-R380.
5. Clemens LE, Almirez RG, Baudouin KA, Mischak RP, Grossbard EB and Protter AA (1998) Pharmacokinetics and biological actions of subcutaneously administered human brain natriuretic peptide. J Pharmacol Exp Ther 287:67-71.
6. Clemens LE, Almirez RG, Baudouin KA, Grossbard EG and Protter AA (1997) Human brain natriuretic peptide reduces blood pressure in normotensive and acute norepinephrine-induced hypertensive rabbits. Am J Hypertens 10:654-661.
7. Hobbs RE, Miller LW, Bott-Silverman C, James KB, Rincon G and Grossbard EB (1996) Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 78:896-901.
8. Kenny AJ, Bourne A and Ingram J (1993) Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem J 291:83-88.
9. Lainchbury JG, Nicholls MG, Espiner EA, Ikram H, Yandle TG and Richards AM (1998) Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man. Clin Sci (Colch) 95:547-555.
10. Lewicki JA and Protter AA (1995) Physiological studies of the natriuretic peptide family, in Hypertension, Pathophysiology, Diagnosis, and Management (Laragh JH and Brenner BM eds) pp 1029-1053, Raven Press, New York.
11. Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA and Lewicki JA (1987) Physiological role of silent receptors of atrial natriuretic factor. Science (Wash)238:675-678.
12. Marcus LS, Hart D, Packer M, Yushak M, Medina N, Danziger RS, Heitjan DF and Katz SD (1996) Hemodynamic and renal excretory effects of human brain peptide infusion in patients with congestive-heart-failure - a double-blind, placebo-controlled, randomized crossover trial. Circulation 94:3184-3189.
13. Mills RM, LeJemtel T, Chatterjee K and Liang C (1997) Hemodynamic effects of a 24 hour infusion of B-type natriuretic peptide (Natrecor) in patients with decompensated heart failure. J Am Coll Cardiol 29:99674.
14. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K and Imura H (1991) Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87:1402-1412.
15. Murthy KS, Teng B, Jin J and Makhlouf GM (1998) G protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor. Am J Physiol 275:C1409-C1416.
16. Norman JA, Little D, Bolgar M and Di Donato G (1991) Degradation of brain natriuretic peptide by neutral endopeptidase: Species specific sites of proteolysis determined by mass spectrometry. Biochem Biophys Res Commun 175:22-30.
17. Nussenzveig DR, Lewicki JA and Maack T (1990) Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. J Biol Chem 265:20952-20958.
18. Okolicany J, McEnroe GA, Koh GY, Lewicki JA and Maack T (1992) Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor. Am J Physiol 263:F546-F553.
19. Rademaker MT, Charles CJ, Kosoglou T, Protter AA, Espiner EA, Nicholls MG and Richards AM (1997) Clearance receptors and endopeptidase: Equal role in natriuretic peptide metabolism in heart failure. Am J Physiol 273:H2372-H2379.
20. Richards AM, Crozier IG, Yandle TG, Espiner EA, Ikram H and Nicholls MG (1993) Brain natriuretic factor: Regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J 69:414-417.
21. Ritschel WA (1992) Handbook of Basic Pharmacokinetics. Drug Intelligence Publications, Inc., Hamilton, IL.
22. Roques BP and Beaumont A (1990) Neutral endopeptidase-24.11 inhibitors: From analgesics to antihypertensives? Trends Pharmacol Sci 11:245-249.
23. Sonnenberg JL, Sakane Y, Jeng AY, Koehn JA, Ansell JA, Wennogle LP and Ghai RD (1988) Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney. Peptides 9:173-180.
24. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, Mukoyama M, Saito Y, Nakao K and Imura H (1991) Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84:1581-1588.